Connect Biopharma Holdings Limited (CNTB)

CNTB Statistics

Total Valuation

CNTB has a market cap or net worth of $89.15 million. The enterprise value is $18.26 million.

Market Cap	89.15M
Enterprise Value	18.26M

Important Dates

The last earnings date was Friday, September 5, 2025, after market close.

Earnings Date	Sep 5, 2025
Ex-Dividend Date	n/a

Share Statistics

CNTB has 55.72 million shares outstanding. The number of shares has increased by 0.44% in one year.

Current Share Class	n/a
Shares Outstanding	55.72M
Shares Change (YoY)	+0.44%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	22.47%
Owned by Institutions (%)	10.52%
Float	14.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	45.07
Forward PS	n/a
PB Ratio	1.25
P/TBV Ratio	1.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.24, with a Debt / Equity ratio of 0.01.

Current Ratio	7.24
Quick Ratio	6.70
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -49.45% and return on invested capital (ROIC) is -33.97%.

Return on Equity (ROE)	-49.45%
Return on Assets (ROA)	-30.58%
Return on Invested Capital (ROIC)	-33.97%
Return on Capital Employed (ROCE)	-69.09%
Revenue Per Employee	$31,694
Profits Per Employee	-$725,048
Employee Count	62
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, CNTB has paid $272,000 in taxes.

Income Tax	272,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-0.08
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	180,139

Short Selling Information

Short Interest	29,537
Short Previous Month	102,420
Short % of Shares Out	0.29%
Short % of Float	n/a
Short Ratio (days to cover)	0.44

Income Statement

In the last 12 months, CNTB had revenue of $1.97 million and -$44.95 million in losses. Loss per share was -$0.81.

Revenue	1.97M
Gross Profit	1.97M
Operating Income	-49.74M
Pretax Income	-59.38M
Net Income	-44.95M
EBITDA	-49.06M
EBIT	-49.74M
Loss Per Share	-$0.81

Balance Sheet

The company has $71.77 million in cash and $870,000 in debt, giving a net cash position of $70.90 million or $1.27 per share.

Cash & Cash Equivalents	71.77M
Total Debt	870,000
Net Cash	70.90M
Net Cash Per Share	$1.27
Equity (Book Value)	71.34M
Book Value Per Share	1.28
Working Capital	67.02M

Cash Flow

In the last 12 months, operating cash flow was -$37.88 million and capital expenditures -$844,000, giving a free cash flow of -$38.72 million.

Operating Cash Flow	-37.88M
Capital Expenditures	-844,000
Free Cash Flow	-38.72M
FCF Per Share	-$0.69

Margins

Gross Margin	100.00%
Operating Margin	-2,531.09%
Pretax Margin	-2,273.84%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNTB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.43%
Shareholder Yield	-0.43%
Earnings Yield	-50.42%
FCF Yield	-43.43%

Analyst Forecast

The average price target for CNTB is $7.50, which is 368.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.50
Price Target Difference	368.75%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	19.82%
EPS Growth Forecast (5Y)	5.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CNTB has an Altman Z-Score of -4.23 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.23
Piotroski F-Score	1